The global Medical-Grade Mannitol Injection market was valued at US$ 272 million in 2025 and is anticipated to reach US$ 416 million by 2032, at a CAGR of 6.2% from 2026 to 2032.

Medical-Grade Mannitol Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical-Grade Mannitol Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Medical mannitol injection is a hypertonic intravenous preparation with mannitol as its main component, and is a commonly used dehydrating agent and osmotic diuretic in clinical practice. It works by increasing plasma osmotic pressure, causing water from interstitial spaces and cells to enter the blood vessels and be rapidly excreted by the kidneys. This achieves the effects of reducing intracranial pressure, reducing intraocular pressure, and promoting diuresis. It is widely used in clinical settings for cerebral edema, intracranial hypertension, acute glaucoma, and for the prevention or treatment of acute renal failure.

The upstream of the medical mannitol injection industry chain mainly includes the production and supply of mannitol raw materials, as well as basic raw materials such as water for injection and packaging materials (such as glass infusion bottles or plastic infusion bags, stoppers, and aluminum caps); the midstream involves the preparation and production of medical mannitol injection, covering key processes such as dissolution, filtration, pyrogen removal, sterile filling, sterilization, quality testing, and regulatory registration, requiring high standards of GMP compliance and production stability; the downstream distribution is through pharmaceutical distribution companies to various levels of hospitals and some primary healthcare institutions, mainly used in clinical departments such as neurosurgery, ophthalmology, emergency medicine, and critical care medicine. It is significantly affected by medical insurance policies, clinical medication guidelines, and changes in medical demand.

In 2025, the average price of medical mannitol injection is US$1 per dose, with sales volume reaching 272 million doses. The gross profit margin of medical mannitol injection is approximately 53%, and the total production capacity is 389 million doses.

The North American market for Medical-Grade Mannitol Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Medical-Grade Mannitol Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Medical-Grade Mannitol Injection include Baxter Healthcare Company, Fresenius Kabi USA, B. Braun Medical, Pfizer, ICU Medical, American Regent, Otsuka Pharmaceuticals, Fresenius Kabi, Nanogen Pharma, Anhui Fengyuan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Medical-Grade Mannitol Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical-Grade Mannitol Injection. The Medical-Grade Mannitol Injection market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Medical-Grade Mannitol Injection market comprehensively. Regional market sizes by Type, by Application, by Packaging Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Medical-Grade Mannitol Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Medical-Grade Mannitol Injection Market Report

Report Metric	Details
Report Name	Medical-Grade Mannitol Injection Market
Accounted market size in 2025	US$ 272 million
Forecasted market size in 2032	US$ 416 million
CAGR	6.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Low Concentration High Concentration
Segment by Packaging Form	Glass Bottles Plastic Infusion Bags
Segment by Usage Scenarios	Standard Clinical Infusion Type Emergency and Critical Care Type
by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter Healthcare Company, Fresenius Kabi USA, B. Braun Medical, Pfizer, ICU Medical, American Regent, Otsuka Pharmaceuticals, Fresenius Kabi, Nanogen Pharma, Anhui Fengyuan Pharmaceutical, Guosen Pharmaceutical, Anhui Globe Pharmaceutical, Cisen Pharmaceutical, Chengdu Brilliant Pharmaceutical, Dongguan Puji Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Packaging Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Medical-Grade Mannitol Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Medical-Grade Mannitol Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Medical-Grade Mannitol Injection Market growing?

Ans: The Medical-Grade Mannitol Injection Market witnessing a CAGR of 6.2% during the forecast period 2026-2032.

What is the Medical-Grade Mannitol Injection Market size in 2032?

Ans: The Medical-Grade Mannitol Injection Market size in 2032 will be US$ 416 million.

Who are the main players in the Medical-Grade Mannitol Injection Market report?

Ans: The main players in the Medical-Grade Mannitol Injection Market are Baxter Healthcare Company, Fresenius Kabi USA, B. Braun Medical, Pfizer, ICU Medical, American Regent, Otsuka Pharmaceuticals, Fresenius Kabi, Nanogen Pharma, Anhui Fengyuan Pharmaceutical, Guosen Pharmaceutical, Anhui Globe Pharmaceutical, Cisen Pharmaceutical, Chengdu Brilliant Pharmaceutical, Dongguan Puji Pharmaceutical

What are the Application segmentation covered in the Medical-Grade Mannitol Injection Market report?

Ans: The Applications covered in the Medical-Grade Mannitol Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Medical-Grade Mannitol Injection Market report?

Ans: The Types covered in the Medical-Grade Mannitol Injection Market report are Low Concentration, High Concentration

1 Medical-Grade Mannitol Injection Market Overview

1.1 Product Definition

1.2 Medical-Grade Mannitol Injection by Type

1.2.1 Global Medical-Grade Mannitol Injection Market Value by Type: 2025 vs 2032

1.2.2 Low Concentration

1.2.3 High Concentration

1.3 Medical-Grade Mannitol Injection by Packaging Form

1.3.1 Global Medical-Grade Mannitol Injection Market Value by Packaging Form: 2025 vs 2032

1.3.2 Glass Bottles

1.3.3 Plastic Infusion Bags

1.4 Medical-Grade Mannitol Injection by Usage Scenarios

1.4.1 Global Medical-Grade Mannitol Injection Market Value by Usage Scenarios: 2025 vs 2032

1.4.2 Standard Clinical Infusion Type

1.4.3 Emergency and Critical Care Type

1.5 Medical-Grade Mannitol Injection by Application

1.5.1 Global Medical-Grade Mannitol Injection Market Value by Application: 2025 vs 2032

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Others

1.6 Global Medical-Grade Mannitol Injection Market Size Estimates and Forecasts

1.6.1 Global Medical-Grade Mannitol Injection Revenue 2021–2032

1.6.2 Global Medical-Grade Mannitol Injection Sales 2021–2032

1.6.3 Global Medical-Grade Mannitol Injection Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Medical-Grade Mannitol Injection Market Competition by Manufacturers

2.1 Global Medical-Grade Mannitol Injection Sales Market Share by Manufacturers (2021–2026)

2.2 Global Medical-Grade Mannitol Injection Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Medical-Grade Mannitol Injection Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Medical-Grade Mannitol Injection, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Medical-Grade Mannitol Injection, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Medical-Grade Mannitol Injection, Product Types and Applications

2.7 Global Key Manufacturers of Medical-Grade Mannitol Injection, Date of Entry into the Industry

2.8 Global Medical-Grade Mannitol Injection Market Competitive Situation and Trends

2.8.1 Global Medical-Grade Mannitol Injection Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Medical-Grade Mannitol Injection Players Market Share by Revenue

2.8.3 Global Medical-Grade Mannitol Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Medical-Grade Mannitol Injection Market Scenario by Region

3.1 Global Medical-Grade Mannitol Injection Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Medical-Grade Mannitol Injection Sales by Region: 2021–2032

3.2.1 Global Medical-Grade Mannitol Injection Sales by Region: 2021–2026

3.2.2 Global Medical-Grade Mannitol Injection Sales by Region: 2027–2032

3.3 Global Medical-Grade Mannitol Injection Revenue by Region: 2021–2032

3.3.1 Global Medical-Grade Mannitol Injection Revenue by Region: 2021–2026

3.3.2 Global Medical-Grade Mannitol Injection Revenue by Region: 2027–2032

3.4 North America Medical-Grade Mannitol Injection Market Facts & Figures by Country

3.4.1 North America Medical-Grade Mannitol Injection Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Medical-Grade Mannitol Injection Sales by Country (2021–2032)

3.4.3 North America Medical-Grade Mannitol Injection Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Medical-Grade Mannitol Injection Market Facts & Figures by Country

3.5.1 Europe Medical-Grade Mannitol Injection Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Medical-Grade Mannitol Injection Sales by Country (2021–2032)

3.5.3 Europe Medical-Grade Mannitol Injection Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Medical-Grade Mannitol Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Medical-Grade Mannitol Injection Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Medical-Grade Mannitol Injection Sales by Region (2021–2032)

3.6.3 Asia Pacific Medical-Grade Mannitol Injection Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Medical-Grade Mannitol Injection Market Facts & Figures by Country

3.7.1 Latin America Medical-Grade Mannitol Injection Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Medical-Grade Mannitol Injection Sales by Country (2021–2032)

3.7.3 Latin America Medical-Grade Mannitol Injection Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Medical-Grade Mannitol Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Medical-Grade Mannitol Injection Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Medical-Grade Mannitol Injection Sales by Country (2021–2032)

3.8.3 Middle East and Africa Medical-Grade Mannitol Injection Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Medical-Grade Mannitol Injection Sales by Type (2021–2032)

4.1.1 Global Medical-Grade Mannitol Injection Sales by Type (2021–2026)

4.1.2 Global Medical-Grade Mannitol Injection Sales by Type (2027–2032)

4.1.3 Global Medical-Grade Mannitol Injection Sales Market Share by Type (2021–2032)

4.2 Global Medical-Grade Mannitol Injection Revenue by Type (2021–2032)

4.2.1 Global Medical-Grade Mannitol Injection Revenue by Type (2021–2026)

4.2.2 Global Medical-Grade Mannitol Injection Revenue by Type (2027–2032)

4.2.3 Global Medical-Grade Mannitol Injection Revenue Market Share by Type (2021–2032)

4.3 Global Medical-Grade Mannitol Injection Price by Type (2021–2032)

5 Segment by Application

5.1 Global Medical-Grade Mannitol Injection Sales by Application (2021–2032)

5.1.1 Global Medical-Grade Mannitol Injection Sales by Application (2021–2026)

5.1.2 Global Medical-Grade Mannitol Injection Sales by Application (2027–2032)

5.1.3 Global Medical-Grade Mannitol Injection Sales Market Share by Application (2021–2032)

5.2 Global Medical-Grade Mannitol Injection Revenue by Application (2021–2032)

5.2.1 Global Medical-Grade Mannitol Injection Revenue by Application (2021–2026)

5.2.2 Global Medical-Grade Mannitol Injection Revenue by Application (2027–2032)

5.2.3 Global Medical-Grade Mannitol Injection Revenue Market Share by Application (2021–2032)

5.3 Global Medical-Grade Mannitol Injection Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Baxter Healthcare Company

6.1.1 Baxter Healthcare Company Company Information

6.1.2 Baxter Healthcare Company Description and Business Overview

6.1.3 Baxter Healthcare Company Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Baxter Healthcare Company Medical-Grade Mannitol Injection Product Portfolio

6.1.5 Baxter Healthcare Company Recent Developments/Updates

6.2 Fresenius Kabi USA

6.2.1 Fresenius Kabi USA Company Information

6.2.2 Fresenius Kabi USA Description and Business Overview

6.2.3 Fresenius Kabi USA Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Fresenius Kabi USA Medical-Grade Mannitol Injection Product Portfolio

6.2.5 Fresenius Kabi USA Recent Developments/Updates

6.3 B. Braun Medical

6.3.1 B. Braun Medical Company Information

6.3.2 B. Braun Medical Description and Business Overview

6.3.3 B. Braun Medical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 B. Braun Medical Medical-Grade Mannitol Injection Product Portfolio

6.3.5 B. Braun Medical Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Pfizer Medical-Grade Mannitol Injection Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 ICU Medical

6.5.1 ICU Medical Company Information

6.5.2 ICU Medical Description and Business Overview

6.5.3 ICU Medical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 ICU Medical Medical-Grade Mannitol Injection Product Portfolio

6.5.5 ICU Medical Recent Developments/Updates

6.6 American Regent

6.6.1 American Regent Company Information

6.6.2 American Regent Description and Business Overview

6.6.3 American Regent Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 American Regent Medical-Grade Mannitol Injection Product Portfolio

6.6.5 American Regent Recent Developments/Updates

6.7 Otsuka Pharmaceuticals

6.7.1 Otsuka Pharmaceuticals Company Information

6.7.2 Otsuka Pharmaceuticals Description and Business Overview

6.7.3 Otsuka Pharmaceuticals Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Otsuka Pharmaceuticals Medical-Grade Mannitol Injection Product Portfolio

6.7.5 Otsuka Pharmaceuticals Recent Developments/Updates

6.8 Fresenius Kabi

6.8.1 Fresenius Kabi Company Information

6.8.2 Fresenius Kabi Description and Business Overview

6.8.3 Fresenius Kabi Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Fresenius Kabi Medical-Grade Mannitol Injection Product Portfolio

6.8.5 Fresenius Kabi Recent Developments/Updates

6.9 Nanogen Pharma

6.9.1 Nanogen Pharma Company Information

6.9.2 Nanogen Pharma Description and Business Overview

6.9.3 Nanogen Pharma Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Nanogen Pharma Medical-Grade Mannitol Injection Product Portfolio

6.9.5 Nanogen Pharma Recent Developments/Updates

6.10 Anhui Fengyuan Pharmaceutical

6.10.1 Anhui Fengyuan Pharmaceutical Company Information

6.10.2 Anhui Fengyuan Pharmaceutical Description and Business Overview

6.10.3 Anhui Fengyuan Pharmaceutical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Anhui Fengyuan Pharmaceutical Medical-Grade Mannitol Injection Product Portfolio

6.10.5 Anhui Fengyuan Pharmaceutical Recent Developments/Updates

6.11 Guosen Pharmaceutical

6.11.1 Guosen Pharmaceutical Company Information

6.11.2 Guosen Pharmaceutical Description and Business Overview

6.11.3 Guosen Pharmaceutical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Guosen Pharmaceutical Medical-Grade Mannitol Injection Product Portfolio

6.11.5 Guosen Pharmaceutical Recent Developments/Updates

6.12 Anhui Globe Pharmaceutical

6.12.1 Anhui Globe Pharmaceutical Company Information

6.12.2 Anhui Globe Pharmaceutical Description and Business Overview

6.12.3 Anhui Globe Pharmaceutical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Anhui Globe Pharmaceutical Medical-Grade Mannitol Injection Product Portfolio

6.12.5 Anhui Globe Pharmaceutical Recent Developments/Updates

6.13 Cisen Pharmaceutical

6.13.1 Cisen Pharmaceutical Company Information

6.13.2 Cisen Pharmaceutical Description and Business Overview

6.13.3 Cisen Pharmaceutical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Cisen Pharmaceutical Medical-Grade Mannitol Injection Product Portfolio

6.13.5 Cisen Pharmaceutical Recent Developments/Updates

6.14 Chengdu Brilliant Pharmaceutical

6.14.1 Chengdu Brilliant Pharmaceutical Company Information

6.14.2 Chengdu Brilliant Pharmaceutical Description and Business Overview

6.14.3 Chengdu Brilliant Pharmaceutical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Chengdu Brilliant Pharmaceutical Medical-Grade Mannitol Injection Product Portfolio

6.14.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates

6.15 Dongguan Puji Pharmaceutical

6.15.1 Dongguan Puji Pharmaceutical Company Information

6.15.2 Dongguan Puji Pharmaceutical Description and Business Overview

6.15.3 Dongguan Puji Pharmaceutical Medical-Grade Mannitol Injection Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Dongguan Puji Pharmaceutical Medical-Grade Mannitol Injection Product Portfolio

6.15.5 Dongguan Puji Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Medical-Grade Mannitol Injection Industry Chain Analysis

7.2 Medical-Grade Mannitol Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Medical-Grade Mannitol Injection Production Mode & Process Analysis

7.4 Medical-Grade Mannitol Injection Sales and Marketing

7.4.1 Medical-Grade Mannitol Injection Sales Channels

7.4.2 Medical-Grade Mannitol Injection Distributors

7.5 Medical-Grade Mannitol Injection Customer Analysis

8 Medical-Grade Mannitol Injection Market Dynamics

8.1 Medical-Grade Mannitol Injection Industry Trends

8.2 Medical-Grade Mannitol Injection Market Drivers

8.3 Medical-Grade Mannitol Injection Market Challenges

8.4 Medical-Grade Mannitol Injection Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Otsuka Pharmaceuticals

Fresenius Kabi

Anhui Fengyuan Pharmaceutical

Guosen Pharmaceutical

ANHUI GLOBE PHARMACEUTICAL

Cisen Pharmaceutical

Chengdu Brilliant Pharmaceutical

Baxter Healthcare Company

Nanogen Pharma

Dongguan Puji Pharmaceutical

List of Tables

Table 1. Global Medical-Grade Mannitol Injection Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Medical-Grade Mannitol Injection Market Value by Packaging Form (US$ Million), 2025 vs 2032

Table 3. Global Medical-Grade Mannitol Injection Market Value by Usage Scenarios (US$ Million), 2025 vs 2032

Table 4. Global Medical-Grade Mannitol Injection Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Medical-Grade Mannitol Injection Market Competitive Situation by Manufacturers in 2025

Table 6. Global Medical-Grade Mannitol Injection Sales (K Dose) of Key Manufacturers (2021–2026)

Table 7. Global Medical-Grade Mannitol Injection Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Medical-Grade Mannitol Injection Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Medical-Grade Mannitol Injection Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Medical-Grade Mannitol Injection Average Price (US$/Dose) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Medical-Grade Mannitol Injection, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Medical-Grade Mannitol Injection, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Medical-Grade Mannitol Injection, Product Types and Applications

Table 14. Global Key Manufacturers of Medical-Grade Mannitol Injection, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Medical-Grade Mannitol Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical-Grade Mannitol Injection Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Medical-Grade Mannitol Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Medical-Grade Mannitol Injection Sales by Region (K Dose), 2021–2026

Table 20. Global Medical-Grade Mannitol Injection Sales Market Share by Region (2021–2026)

Table 21. Global Medical-Grade Mannitol Injection Sales by Region (K Dose), 2027–2032

Table 22. Global Medical-Grade Mannitol Injection Sales Market Share by Region (2027–2032)

Table 23. Global Medical-Grade Mannitol Injection Revenue by Region (US$ Million), 2021–2026

Table 24. Global Medical-Grade Mannitol Injection Revenue Market Share by Region (2021–2026)

Table 25. Global Medical-Grade Mannitol Injection Revenue by Region (US$ Million), 2027–2032

Table 26. Global Medical-Grade Mannitol Injection Revenue Market Share by Region (2027–2032)

Table 27. North America Medical-Grade Mannitol Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Medical-Grade Mannitol Injection Sales by Country (K Dose), 2021–2026

Table 29. North America Medical-Grade Mannitol Injection Sales by Country (K Dose), 2027–2032

Table 30. North America Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2021–2026

Table 31. North America Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Medical-Grade Mannitol Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Medical-Grade Mannitol Injection Sales by Country (K Dose), 2021–2026

Table 34. Europe Medical-Grade Mannitol Injection Sales by Country (K Dose), 2027–2032

Table 35. Europe Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Medical-Grade Mannitol Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Medical-Grade Mannitol Injection Sales by Region (K Dose), 2021–2026

Table 39. Asia Pacific Medical-Grade Mannitol Injection Sales by Region (K Dose), 2027–2032

Table 40. Asia Pacific Medical-Grade Mannitol Injection Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Medical-Grade Mannitol Injection Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Medical-Grade Mannitol Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Medical-Grade Mannitol Injection Sales by Country (K Dose), 2021–2026

Table 44. Latin America Medical-Grade Mannitol Injection Sales by Country (K Dose), 2027–2032

Table 45. Latin America Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Medical-Grade Mannitol Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Medical-Grade Mannitol Injection Sales by Country (K Dose), 2021–2026

Table 49. Middle East and Africa Medical-Grade Mannitol Injection Sales by Country (K Dose), 2027–2032

Table 50. Middle East and Africa Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Medical-Grade Mannitol Injection Revenue by Country (US$ Million), 2027–2032

Table 52. Global Medical-Grade Mannitol Injection Sales (K Dose) by Type (2021–2026)

Table 53. Global Medical-Grade Mannitol Injection Sales (K Dose) by Type (2027–2032)

Table 54. Global Medical-Grade Mannitol Injection Sales Market Share by Type (2021–2026)

Table 55. Global Medical-Grade Mannitol Injection Sales Market Share by Type (2027–2032)

Table 56. Global Medical-Grade Mannitol Injection Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Medical-Grade Mannitol Injection Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Medical-Grade Mannitol Injection Revenue Market Share by Type (2021–2026)

Table 59. Global Medical-Grade Mannitol Injection Revenue Market Share by Type (2027–2032)

Table 60. Global Medical-Grade Mannitol Injection Price (US$/Dose) by Type (2021–2026)

Table 61. Global Medical-Grade Mannitol Injection Price (US$/Dose) by Type (2027–2032)

Table 62. Global Medical-Grade Mannitol Injection Sales (K Dose) by Application (2021–2026)

Table 63. Global Medical-Grade Mannitol Injection Sales (K Dose) by Application (2027–2032)

Table 64. Global Medical-Grade Mannitol Injection Sales Market Share by Application (2021–2026)

Table 65. Global Medical-Grade Mannitol Injection Sales Market Share by Application (2027–2032)

Table 66. Global Medical-Grade Mannitol Injection Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Medical-Grade Mannitol Injection Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Medical-Grade Mannitol Injection Revenue Market Share by Application (2021–2026)

Table 69. Global Medical-Grade Mannitol Injection Revenue Market Share by Application (2027–2032)

Table 70. Global Medical-Grade Mannitol Injection Price (US$/Dose) by Application (2021–2026)

Table 71. Global Medical-Grade Mannitol Injection Price (US$/Dose) by Application (2027–2032)

Table 72. Baxter Healthcare Company Company Information

Table 73. Baxter Healthcare Company Description and Business Overview

Table 74. Baxter Healthcare Company Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 75. Baxter Healthcare Company Medical-Grade Mannitol Injection Product

Table 76. Baxter Healthcare Company Recent Developments/Updates

Table 77. Fresenius Kabi USA Company Information

Table 78. Fresenius Kabi USA Description and Business Overview

Table 79. Fresenius Kabi USA Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 80. Fresenius Kabi USA Medical-Grade Mannitol Injection Product

Table 81. Fresenius Kabi USA Recent Developments/Updates

Table 82. B. Braun Medical Company Information

Table 83. B. Braun Medical Description and Business Overview

Table 84. B. Braun Medical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 85. B. Braun Medical Medical-Grade Mannitol Injection Product

Table 86. B. Braun Medical Recent Developments/Updates

Table 87. Pfizer Company Information

Table 88. Pfizer Description and Business Overview

Table 89. Pfizer Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 90. Pfizer Medical-Grade Mannitol Injection Product

Table 91. Pfizer Recent Developments/Updates

Table 92. ICU Medical Company Information

Table 93. ICU Medical Description and Business Overview

Table 94. ICU Medical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 95. ICU Medical Medical-Grade Mannitol Injection Product

Table 96. ICU Medical Recent Developments/Updates

Table 97. American Regent Company Information

Table 98. American Regent Description and Business Overview

Table 99. American Regent Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 100. American Regent Medical-Grade Mannitol Injection Product

Table 101. American Regent Recent Developments/Updates

Table 102. Otsuka Pharmaceuticals Company Information

Table 103. Otsuka Pharmaceuticals Description and Business Overview

Table 104. Otsuka Pharmaceuticals Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 105. Otsuka Pharmaceuticals Medical-Grade Mannitol Injection Product

Table 106. Otsuka Pharmaceuticals Recent Developments/Updates

Table 107. Fresenius Kabi Company Information

Table 108. Fresenius Kabi Description and Business Overview

Table 109. Fresenius Kabi Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 110. Fresenius Kabi Medical-Grade Mannitol Injection Product

Table 111. Fresenius Kabi Recent Developments/Updates

Table 112. Nanogen Pharma Company Information

Table 113. Nanogen Pharma Description and Business Overview

Table 114. Nanogen Pharma Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 115. Nanogen Pharma Medical-Grade Mannitol Injection Product

Table 116. Nanogen Pharma Recent Developments/Updates

Table 117. Anhui Fengyuan Pharmaceutical Company Information

Table 118. Anhui Fengyuan Pharmaceutical Description and Business Overview

Table 119. Anhui Fengyuan Pharmaceutical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 120. Anhui Fengyuan Pharmaceutical Medical-Grade Mannitol Injection Product

Table 121. Anhui Fengyuan Pharmaceutical Recent Developments/Updates

Table 122. Guosen Pharmaceutical Company Information

Table 123. Guosen Pharmaceutical Description and Business Overview

Table 124. Guosen Pharmaceutical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 125. Guosen Pharmaceutical Medical-Grade Mannitol Injection Product

Table 126. Guosen Pharmaceutical Recent Developments/Updates

Table 127. Anhui Globe Pharmaceutical Company Information

Table 128. Anhui Globe Pharmaceutical Description and Business Overview

Table 129. Anhui Globe Pharmaceutical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 130. Anhui Globe Pharmaceutical Medical-Grade Mannitol Injection Product

Table 131. Anhui Globe Pharmaceutical Recent Developments/Updates

Table 132. Cisen Pharmaceutical Company Information

Table 133. Cisen Pharmaceutical Description and Business Overview

Table 134. Cisen Pharmaceutical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 135. Cisen Pharmaceutical Medical-Grade Mannitol Injection Product

Table 136. Cisen Pharmaceutical Recent Developments/Updates

Table 137. Chengdu Brilliant Pharmaceutical Company Information

Table 138. Chengdu Brilliant Pharmaceutical Description and Business Overview

Table 139. Chengdu Brilliant Pharmaceutical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 140. Chengdu Brilliant Pharmaceutical Medical-Grade Mannitol Injection Product

Table 141. Chengdu Brilliant Pharmaceutical Recent Developments/Updates

Table 142. Dongguan Puji Pharmaceutical Company Information

Table 143. Dongguan Puji Pharmaceutical Description and Business Overview

Table 144. Dongguan Puji Pharmaceutical Medical-Grade Mannitol Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)

Table 145. Dongguan Puji Pharmaceutical Medical-Grade Mannitol Injection Product

Table 146. Dongguan Puji Pharmaceutical Recent Developments/Updates

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Medical-Grade Mannitol Injection Distributors List

Table 150. Medical-Grade Mannitol Injection Customers List

Table 151. Medical-Grade Mannitol Injection Market Trends

Table 152. Medical-Grade Mannitol Injection Market Drivers

Table 153. Medical-Grade Mannitol Injection Market Challenges

Table 154. Medical-Grade Mannitol Injection Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

Table 158. Authors List of This Report

List of Figures

Figure 1. Product Picture of Medical-Grade Mannitol Injection

Figure 2. Global Medical-Grade Mannitol Injection Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Medical-Grade Mannitol Injection Market Share by Type: 2025 & 2032

Figure 4. Low Concentration Product Picture

Figure 5. High Concentration Product Picture

Figure 6. Global Medical-Grade Mannitol Injection Market Value by Packaging Form (US$ Million), 2021–2032

Figure 7. Global Medical-Grade Mannitol Injection Market Share by Packaging Form: 2025 vs 2032

Figure 8. Glass Bottles Product Picture

Figure 9. Plastic Infusion Bags Product Picture

Figure 10. Global Medical-Grade Mannitol Injection Market Value by Usage Scenarios (US$ Million), 2021–2032

Figure 11. Global Medical-Grade Mannitol Injection Market Share by Usage Scenarios: 2025 vs 2032

Figure 12. Standard Clinical Infusion Type Product Picture

Figure 13. Emergency and Critical Care Type Product Picture

Figure 14. Global Medical-Grade Mannitol Injection Market Value by Application (US$ Million), 2021–2032

Figure 15. Global Medical-Grade Mannitol Injection Market Share by Application: 2025 & 2032

Figure 16. Hospital

Figure 17. Clinic

Figure 18. Others

Figure 19. Global Medical-Grade Mannitol Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global Medical-Grade Mannitol Injection Market Size (US$ Million), 2021–2032

Figure 21. Global Medical-Grade Mannitol Injection Sales (K Dose), 2021–2032

Figure 22. Global Medical-Grade Mannitol Injection Average Price (US$/Dose), 2021–2032

Figure 23. Medical-Grade Mannitol Injection Report Years Considered

Figure 24. Medical-Grade Mannitol Injection Sales Share by Manufacturers in 2025

Figure 25. Global Medical-Grade Mannitol Injection Revenue Share by Manufacturers in 2025

Figure 26. Top 5 and Top 10 Global Medical-Grade Mannitol Injection Players: Market Share by Revenue in Medical-Grade Mannitol Injection in 2025

Figure 27. Medical-Grade Mannitol Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 28. Global Medical-Grade Mannitol Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 29. North America Medical-Grade Mannitol Injection Sales Market Share by Country (2021–2032)

Figure 30. North America Medical-Grade Mannitol Injection Revenue Market Share by Country (2021–2032)

Figure 31. United States Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Canada Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Europe Medical-Grade Mannitol Injection Sales Market Share by Country (2021–2032)

Figure 34. Europe Medical-Grade Mannitol Injection Revenue Market Share by Country (2021–2032)

Figure 35. Germany Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. France Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. U.K. Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Italy Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Russia Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Asia Pacific Medical-Grade Mannitol Injection Sales Market Share by Region (2021–2032)

Figure 41. Asia Pacific Medical-Grade Mannitol Injection Revenue Market Share by Region (2021–2032)

Figure 42. China Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Japan Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. South Korea Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. India Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Australia Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. China Taiwan Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Southeast Asia Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Latin America Medical-Grade Mannitol Injection Sales Market Share by Country (2021–2032)

Figure 50. Latin America Medical-Grade Mannitol Injection Revenue Market Share by Country (2021–2032)

Figure 51. Mexico Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Brazil Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Argentina Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Colombia Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Middle East and Africa Medical-Grade Mannitol Injection Sales Market Share by Country (2021–2032)

Figure 56. Middle East and Africa Medical-Grade Mannitol Injection Revenue Market Share by Country (2021–2032)

Figure 57. Turkey Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Saudi Arabia Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. UAE Medical-Grade Mannitol Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Global Sales Market Share of Medical-Grade Mannitol Injection by Type (2021–2032)

Figure 61. Global Revenue Market Share of Medical-Grade Mannitol Injection by Type (2021–2032)

Figure 62. Global Medical-Grade Mannitol Injection Price (US$/Dose) by Type (2021–2032)

Figure 63. Global Sales Market Share of Medical-Grade Mannitol Injection by Application (2021–2032)

Figure 64. Global Revenue Market Share of Medical-Grade Mannitol Injection by Application (2021–2032)

Figure 65. Global Medical-Grade Mannitol Injection Price (US$/Dose) by Application (2021–2032)

Figure 66. Medical-Grade Mannitol Injection Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions